Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (151-160 of 466) with videos related to

Pageof 47
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2004
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterationsCarsten Schwaenen, Michelle Nessling, Swen Wessendorf, et al.
British Journal of Haematology|November 15, 2019
TBET-expressing Th1 CD4<sup>+</sup> T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 micePhilipp M Roessner, Bola S Hanna, Selcen Öztürk, et al.
Frontiers in Oncology|September 28, 2020
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After RituximabIgor Kos, Benedikt Balensiefer, Sophie Roth, et al.
International Journal of Cancer|February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemiaConstance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Blood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Blood|August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialThorsten Zenz, Sonja Häbe, Tina Denzel, et al.
Leukemia|September 30, 2018
Control of chronic lymphocytic leukemia development by clonally-expanded CD8<sup>+</sup> T-cells that undergo functional exhaustion in secondary lymphoid tissuesBola S Hanna, Philipp M Roessner, Haniyeh Yazdanparast, et al.
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Cancer Cell|August 18, 2012
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesisSandrine Sander, Dinis P Calado, Lakshmi Srinivasan, et al.
Cancers|March 13, 2024
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient CareMary Ann Anderson, Renata Walewska, Fidelma Hackett, et al.
Pageof 47

Showing results (151-160 of 466) with videos related to

Sort By:
Pageof 47
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2004
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterationsCarsten Schwaenen, Michelle Nessling, Swen Wessendorf, et al.
British Journal of Haematology|November 15, 2019
TBET-expressing Th1 CD4<sup>+</sup> T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 micePhilipp M Roessner, Bola S Hanna, Selcen Öztürk, et al.
Frontiers in Oncology|September 28, 2020
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After RituximabIgor Kos, Benedikt Balensiefer, Sophie Roth, et al.
International Journal of Cancer|February 24, 2015
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemiaConstance Baer, Christopher C Oakes, Amy S Ruppert, et al.
Blood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Blood|August 1, 2009
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trialThorsten Zenz, Sonja Häbe, Tina Denzel, et al.
Leukemia|September 30, 2018
Control of chronic lymphocytic leukemia development by clonally-expanded CD8<sup>+</sup> T-cells that undergo functional exhaustion in secondary lymphoid tissuesBola S Hanna, Philipp M Roessner, Haniyeh Yazdanparast, et al.
Bone Marrow Transplantation|July 25, 2020
Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapyTorben Rixecker, Vadim Lesan, Manfred Ahlgrimm, et al.
Cancer Cell|August 18, 2012
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesisSandrine Sander, Dinis P Calado, Lakshmi Srinivasan, et al.
Cancers|March 13, 2024
Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient CareMary Ann Anderson, Renata Walewska, Fidelma Hackett, et al.
Pageof 47